David Tuller
Trial By Error: Professor White & Colleagues “Regret” Ignoring Null Results in GETSET Trial Follow-Up
By David Tuller
By David Tuller, DrPHLast week, I wrote about the correction made to the "Highlights" section of the paper reporting the long-term follow-up results for the GETSET trial. (The trial was conducted by Professor Peter White, one of the three lead PACE investigators, and colleagues.) I noted that this correction was ...
Trial By Error: Quartet of Trials Reveals Limitations of CBT for “Medically Unexplained Symptoms”
By David Tuller
By David Tuller, DrPH A year ago, I wrote a post about how the biopsychosocial ideological brigades had completed a trifecta of major studies that investigated cognitive behavior therapy for a variety of so-called “medically unexplained symptoms” (MUS). As a group, the studies demonstrated the overall ineffectiveness of CBT as ...
Trial By Error: Journal Corrects “Highlights” of GETSET Paper; A Letter about Prof White’s GET Safety Paper
By David Tuller
By David Tuller, DrPH I have pressed the Journal of Psychosomatic Research to correct a recent paper, "Guided graded exercise self-help for chronic fatigue syndrome: Long term follow up and cost-effectiveness following the GETSET trial.” The senior author is Professor Peter White. Now the journal has published a revised “Highlights” ...
Trial By Error: Lowenstein’s Guardian Opinion; Eliot Smith’s Post-NICE View; Tack’s Take on Blinding Study
By David Tuller
By David Tuller, DrPH The Guardian has published a lot of nonsense about Long COVID and has provided a platform for people who argue that robust manly thoughts are the path to recovery. Of course, it also published George Monbiot's powerful columns on the topic, including his rebuttal of silly ...
Trial By Error: Did the IBS Trial Really Show that Web-Based CBT Offered Significant Clinical Effectiveness?
By David Tuller
By David Tuller, DrPH I wrote some posts last year about the ACTIB trial--a major study of telephone-delivered and web-delivered cognitive behavior therapy (TCBT and WCBT) for irritable bowel syndrome (IBS). Contrary to how the results have been framed by those with reputational and financial interests in promoting them, the ...
